Enhanced Bacterial Extract-Based Solutions for Sensitive Skin Treatment

Publication ID: 24-11857578_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Bacterial Extract-Based Solutions for Sensitive Skin Treatment,” Published Technical Disclosure No. 24-11857578_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857578_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,578.

Summary of the Inventive Concept

This inventive concept presents a suite of improvements and enhancements to the original bacterial extract-based dermatological composition, offering faster, safer, and more efficient treatment options for sensitive skin.

Background and Problem Solved

The original patent disclosed a novel bacterial extract for treating sensitive skin, but it had limitations in terms of extraction methods, stability, and personalized treatment. This new inventive concept addresses these limitations by introducing novel microfluidic extraction, enhanced stability through lyophilization, and personalized treatment options.

Detailed Description of the Inventive Concept

The inventive concept comprises four key aspects: (1) a novel microfluidic extraction method for obtaining bacterial extracts, (2) a method for enhancing the stability of the extract through lyophilization, (3) a dermatological composition that combines the bacterial extract with an anti-inflammatory agent, and (4) a system for real-time monitoring of skin inflammation and personalized treatment. These aspects work in tandem to provide a more efficient, safe, and personalized treatment for sensitive skin.

Novelty and Inventive Step

The new claims introduce novel and non-obvious improvements to the original patent, including the use of microfluidic extraction, lyophilization for stability, and personalized treatment options. These enhancements demonstrate a significant inventive step beyond the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different microfluidic extraction methods, varying stabilizing agents, or alternative anti-inflammatory agents. Additionally, the system for real-time monitoring and personalized treatment could be adapted for use with other skin conditions or therapeutic areas.

Potential Commercial Applications and Market

The enhanced bacterial extract-based solutions have significant commercial potential in the dermatological and cosmetic industries, particularly in the growing market for sensitive skin treatments. The inventive concept's focus on personalized treatment and real-time monitoring also opens up opportunities for digital health and telemedicine applications.

Original Patent Information

Patent NumberUS 11,857,578
TitleExtract and dermatological composition comprising same, for treating sensitive skin
Assignee(s)PIERRE FABRE DERMO-COSMETIQUE